Orchard Therapeutics
ORTX
#7104
Rank
NZ$0.64 B
Marketcap
$28.39
Share price
0.00%
Change (1 day)
253.55%
Change (1 year)

Revenue for Orchard Therapeutics (ORTX)

Revenue in 2023 (TTM): NZ$35.54 Million

According to Orchard Therapeutics 's latest financial reports the company's current revenue (TTM ) is NZ$37.12 Million. In 2022 the company made a revenue of NZ$35.68 Million an increase over the revenue in the year 2021 that were of NZ$2.45 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Orchard Therapeutics from 2019 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) NZ$35.54 M-0.39%
2022 NZ$35.68 M1355.09%
2021 NZ$2.45 M-31.81%
2020 NZ$3.59 M-3.62%
2019 NZ$3.73 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$0.98 B 2,545.44% Jersey
NZ$1.33 B 3,493.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.12 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.12 M 0.00%๐Ÿ‡ฌ๐Ÿ‡ง UK